Journal of Clinical and Preventive Cardiology

REVIEW ARTICLE
Year
: 2018  |  Volume : 7  |  Issue : 2  |  Page : 54--59

Peripartum cardiomyopathy: A contemporary review


Akshai Bhandary, Tarak Rambhatla, Neil Coplan, Itzhak Kronzon 
 Department of Cardiovascular Medicine, Lenox Hill Hospital, Northwell Health, New York, NY, USA

Correspondence Address:
Dr. Itzhak Kronzon
Hofstra College of Medicine, Lenox Hill Hospital, New York, NY
USA

Peripartum cardiomyopathy (PPCM) is a rare, potentially life-threatening disorder affecting women in late pregnancy and the postpartum period. Historically, PPCM was not recognized as a separate disease entity until the 1930s. Further research has since led to the identification of at-risk demographics, theories on etiology, and new targets of therapy. Management to date has largely been focused on guideline-based treatment for heart failure with reduced ejection fraction. However, newer studies have shown the efficacy of novel therapies. In this article, we will review the pathogenesis and diagnosis of PPCM and conclude with some of the newest therapies being offered.


How to cite this article:
Bhandary A, Rambhatla T, Coplan N, Kronzon I. Peripartum cardiomyopathy: A contemporary review.J Clin Prev Cardiol 2018;7:54-59


How to cite this URL:
Bhandary A, Rambhatla T, Coplan N, Kronzon I. Peripartum cardiomyopathy: A contemporary review. J Clin Prev Cardiol [serial online] 2018 [cited 2019 Aug 21 ];7:54-59
Available from: http://www.jcpconline.org/article.asp?issn=2250-3528;year=2018;volume=7;issue=2;spage=54;epage=59;aulast=Bhandary;type=0